TRK-950

N/A

Report date: 2023/11/06 14:03:16

Base Information

Drug NameTRK-950
Drug Alias NameTRK-950
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Caprin-1
TargetsCaprin-1
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsSolid tumoursUrinary Bladder Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSouth Korea +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesToray Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesToray Industries Inc
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsSolid tumoursUrinary Bladder Neoplasms +[12] 
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A